These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8441739)

  • 1. Comparison of hepatic drug-oxidizing activity after simultaneous administration of two probe drugs, caffeine and trimethadione, to human subjects.
    Tanaka E; Ishikawa A; Yamamoto Y; Osada A; Tsuji K; Fukao K; Iwasaki Y
    Pharmacol Toxicol; 1993 Jan; 72(1):31-3. PubMed ID: 8441739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified test for determination of drug-oxidizing capacity in rats with chemical-induced liver injury using caffeine and trimethadione as model drugs.
    Tanaka E; Ishikawa A; Misawa S
    Pharmacol Toxicol; 1992 Mar; 70(3):177-80. PubMed ID: 1579543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in caffeine, lidocaine and trimethadione metabolism in carbon tetrachloride-intoxicated rats as assessed by a "cocktail" study.
    Tanaka E; Ishikawa A; Misawa S
    Pharmacol Toxicol; 1994; 75(3-4):150-3. PubMed ID: 7800655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man.
    Tanaka E; Nakamura K
    Eur J Clin Pharmacol; 1989; 36(6):629-32. PubMed ID: 2776822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified approach for evaluation of hepatic drug-oxidizing activity with a simultaneous determination of caffeine and trimethadione and their demethylated metabolites in rats with a selective cytochrome P-450 inducer.
    Tanaka E; Ishikawa A; Yamamoto Y; Uchida E; Kobayashi S; Yasuhara H; Misawa S
    Biopharm Drug Dispos; 1992 May; 13(4):263-72. PubMed ID: 1600112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites.
    Tanaka E; Ishikawa A; Yamamoto Y; Osada A; Tsuji K; Fukao K; Misawa S; Iwasaki Y
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):336-41. PubMed ID: 1428297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the enzymatic activities of beagle liver during maturation as assessed both in vitro and in vivo.
    Tanaka E; Narisawa C; Nakamura H; Sawa Y; Etoh H; Tadano K; Horie T; Ohkawa H; Misawa S
    Xenobiotica; 1998 Aug; 28(8):795-802. PubMed ID: 9741958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of E-5110, a novel non-steroidal anti-inflammatory drug, on trimethadione metabolism as an indicator of hepatic drug-oxidizing capacity in beagle dog.
    Daling Z; Tanaka E; Nakamura T; Horie T
    Xenobiotica; 1994 Mar; 24(3):215-20. PubMed ID: 8009884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.
    Zandvliet AS; Huitema AD; de Jonge ME; den Hoed R; Sparidans RW; Hendriks VM; van den Brink W; van Ree JM; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):71-9. PubMed ID: 15667599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified approach for evaluation of hepatic drug-oxidizing capacity with a simultaneous measurement of caffeine and its primary demethylated metabolites in carbon tetrachloride-intoxicated rats.
    Tanaka E; Ishikawa A; Yamamoto Y; Uchida E; Kobayashi S; Yasuhara H; Misawa S
    Xenobiotica; 1992 May; 22(5):535-41. PubMed ID: 1413868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurements of caffeine and plasma metabolite/caffeine ratios as a test for hepatic drug-oxidizing capacity in goats.
    Uney K; Tumer I; Traş B
    Xenobiotica; 2011 Jul; 41(7):585-92. PubMed ID: 21476905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
    Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
    J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual effects of a novel thienodiazepine platelet-activating factor antagonist, on drug-oxidizing enzymes in beagle dog.
    Tanaka E; Daling Z; Abe K; Nakamura T; Horie T
    Xenobiotica; 1994 Apr; 24(4):293-300. PubMed ID: 8059533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
    Campbell ME; Grant DM; Inaba T; Kalow W
    Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys.
    Peck K; Mealey KL; Matthews NS; Taylor TS
    Am J Vet Res; 1997 Aug; 58(8):881-4. PubMed ID: 9256975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum metabolite/caffeine ratios as a test for liver function.
    Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
    J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
    Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
    J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of caffeine elimination and Child's classification in liver cirrhosis.
    Holstege A; Staiger M; Haag K; Gerok W
    Klin Wochenschr; 1989 Jan; 67(1):6-15. PubMed ID: 2921843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians.
    Akinyinka OO; Sowunmi A; Honeywell R; Renwick AG
    Eur J Clin Pharmacol; 2000 May; 56(2):159-65. PubMed ID: 10877011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of the paraxanthine/caffeine ratio in the saliva of patients with liver cirrhosis].
    Perlík F; Pucelíková T; Slanar O
    Cas Lek Cesk; 2001 Feb; 140(2):51-3. PubMed ID: 11262908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.